Changes to the NDSS
Find out more about changes to NDSS products and services.
Eligibility expansion for all people with type 1 diabetes to access subsidised CGM and Flash GM products through the NDSS
Updated 27 June 2022
During the recent federal election campaign, the Government committed to provide subsidised access to continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) technology for all people living with type 1 diabetes.
The rollout of this expansion will start on 1 July 2022. From this date, all people with type 1 diabetes will be able to apply for access to subsidised CGM and Flash GM products through the NDSS.
From 1 July 2022, information will be available on the NDSS website to provide guidance for people with type 1 diabetes and health professionals. The process to apply for access to subsidised products will depend on whether a person has used CGM or Flash GM before (either accessed through the NDSS or directly from a product supplier).
Diabetes Australia and the NDSS is available to assist and provide guidance for newly eligible people with type 1 diabetes about accessing subsidised CGM and Flash GM through the NDSS. Diabetes health professionals can provide assistance, education and training once the rollout commences.
Previous important announcements
- Changes to CGM Initiative from 30 May 2022: FreeStyle Libre sensors—DELISTING
- Changes to CGM Initiative from 1 March 2022: Dexcom G5 Mobile
- Changes to CGM Initiative from 1 August 2021: FreeStyle Libre 2
- Changes to CGM Initiative from 18 January 2021: Dexcom G6, Medtronic and authorised certifiers
- Changes to CGM Initiative from 1 March 2020: FreeStyle Libre added and eligibility criteria streamlined
- Government funding boost enables more people to access new glucose monitoring devices through the NDSS from 1 March 2019